AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9393425 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone quality types 1 and 4
Number of subjects: 2839
Study 9393425 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone quality type 2
Number of subjects: 2839
Study 9393425 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone quality type 3
Number of subjects: 2839
Study 9393425 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior mandible
Number of subjects: 2839
Study 9393425 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior mandible
Number of subjects: 2839
Study 9393425 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior and posterior jaw regions
Number of subjects: 2839
Study 8204277 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate cream
Number of subjects: 50
Study 8204277 — intervention group
Group type: COMPARATOR
Intervention: Base cream
Number of subjects: 50
Study 3117165 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous 4 metric polydioxanone (PDX); 374 patients
Number of subjects: 757
Study 3117165 — intervention group
Group type: COMPARATOR
Intervention: Continuous 4 metric polypropylene (PPL); 383 patients
Number of subjects: 757
Study 31279749 — intervention group
Group type: EXPERIMENTAL
Intervention: G8 screening followed by comprehensive geriatric assessment (CGA) and multidisciplinary team conference
Number of subjects: 96
Study 31279749 — intervention group
Group type: COMPARATOR
Intervention: Standard assessment based on oncologist's clinical judgement (control)
Number of subjects: 96
Study 31279749 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 31279749 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 96
Study 29861263 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Manipulation (SM)
Number of subjects: 42
Study 29861263 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Manipulation plus Kinesio Taping (SM + KT)
Number of subjects: 42
Study 29861263 — intervention group
Group type: COMPARATOR
Intervention: Control (SM)
Number of subjects: 42
Study 29861263 — intervention group
Group type: COMPARATOR
Intervention: Control (SM + KT)
Number of subjects: 42
Study 26696251 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose rabbit anti-thymocyte globulin (SD-rATG) 6 mg/kg
Number of subjects: 95
Study 26696251 — intervention group
Group type: COMPARATOR
Intervention: Divided-dose rabbit anti-thymocyte globulin (DD-rATG) 1.5 mg/kg/dose
Number of subjects: 95
Study 26696251 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SD-rATG and DD-rATG
Number of subjects: 95
Study 25616646 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months of clopidogrel
Number of subjects: 4000
Study 25616646 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 months of clopidogrel
Number of subjects: 4000
Study 23673440 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 36
Study 23673440 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 36
Study 20550020 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole 0.25 mg
Number of subjects: 34
Study 20550020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 20550020 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 34
Study 18086798 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab plus CHVP-I
Number of subjects: 194
Study 18086798 — intervention group
Group type: COMPARATOR
Intervention: CHVP-I
Number of subjects: 194
Study 15684166 — intervention group
Group type: COMPARATOR
Intervention: 50 microg of sublingual misoprostol
Number of subjects: 212
Study 15684166 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 microg of sublingual misoprostol
Number of subjects: 212
Study 12851519 — intervention group
Group type: COMPARATOR
Intervention: HRT (n = 43)
Number of subjects: 127
Study 12851519 — intervention group
Group type: COMPARATOR
Intervention: PL (equivalent to 100 mg isoflavone; n = 45)
Number of subjects: 127
Study 12851519 — intervention group
Group type: COMPARATOR
Intervention: PL (n = 45)
Number of subjects: 127
Study 10566461 — intervention group
Group type: EXPERIMENTAL
Intervention: Online vaccine reminders
Number of subjects: 2
Study 10566461 — intervention group
Group type: COMPARATOR
Intervention: Control (no reminders)
Number of subjects: 2
Study 9093647 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylocaine 10% spray
Number of subjects: 0
Study 9093647 — intervention group
Group type: EXPERIMENTAL
Intervention: Silkospray
Number of subjects: 0
Study 9093647 — intervention group
Group type: EXPERIMENTAL
Intervention: Endosgel
Number of subjects: 0
Study 9093647 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 0
Study 1910697 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine (4 mg/kg of 4% lidocaine)
Number of subjects: 133
Study 1910697 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lidocaine)
Number of subjects: 133
Study 6293259 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of chemotherapy and irradiation
Number of subjects: 153
Study 6293259 — intervention group
Group type: COMPARATOR
Intervention: Irradiation
Number of subjects: 153
Study 6293259 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative treatment (irradiation)
Number of subjects: 153
Study 6293259 — intervention group
Group type: EXPERIMENTAL
Intervention: Primarily operated patients
Number of subjects: 153
Study 6293259 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients operated upon after preoperative treatment
Number of subjects: 153
Study 6293259 — intervention group
Group type: EXPERIMENTAL
Intervention: Size of the residual tumour and tumor grade
Number of subjects: 153
Study 30789387 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Drainage (PCD)
Number of subjects: 86
Study 30789387 — intervention group
Group type: COMPARATOR
Intervention: Peritoneal Lavage (PL)
Number of subjects: 86
Study 29377951 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior approach
Number of subjects: 80
Study 29377951 — intervention group
Group type: COMPARATOR
Intervention: Lateral approach
Number of subjects: 80
Study 26967236 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (systolic blood pressure target of less than 120 mm Hg)
Number of subjects: 9361
Study 26967236 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (systolic blood pressure target of less than 140 mm Hg)
Number of subjects: 9361
Study 26967236 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 9361
Study 26967236 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 9361
Study 24112099 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 120
Study 24112099 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating diet
Number of subjects: 120
Study 22313522 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrot juice (Study 1)
Number of subjects: 127
Study 22313522 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinach powder (Study 1)
Number of subjects: 127
Study 22313522 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein and zeaxanthin supplements (Study 2)
Number of subjects: 127
Study 22313522 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Study 2)
Number of subjects: 127
Study 22313522 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein and zeaxanthin-rich foods
Number of subjects: 127
Study 22313522 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein and zeaxanthin supplements
Number of subjects: 127
Study 22313522 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MPL (both studies)
Number of subjects: 127
Study 19962805 — intervention group
Group type: EXPERIMENTAL
Intervention: Online hemodiafiltration (HDF)
Number of subjects: 493
Study 19962805 — intervention group
Group type: COMPARATOR
Intervention: Low-flux hemodialysis (HD)
Number of subjects: 493
Study 17386108 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain radiotherapy (WBRT)
Number of subjects: 174
Study 17386108 — intervention group
Group type: EXPERIMENTAL
Intervention: RPA class I
Number of subjects: 174
Study 17386108 — intervention group
Group type: EXPERIMENTAL
Intervention: RPA class II
Number of subjects: 174
Study 17386108 — intervention group
Group type: EXPERIMENTAL
Intervention: RPA class III
Number of subjects: 174
Study 17386108 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Karnofsky Performance Status (KPS)
Number of subjects: 174
Study 17386108 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurosurgery
Number of subjects: 174
Study 17386108 — intervention group
Group type: EXPERIMENTAL
Intervention: Single metastases
Number of subjects: 174
Study 17386108 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain metastases score (BS-BM)
Number of subjects: 174
Study 17386108 — intervention group
Group type: EXPERIMENTAL
Intervention: Control of primary tumor
Number of subjects: 174
Study 17386108 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of extracranial metastases
Number of subjects: 174
Study 14752633 — intervention group
Group type: EXPERIMENTAL
Intervention: LapSim
Number of subjects: 24
Study 14752633 — intervention group
Group type: EXPERIMENTAL
Intervention: Box trainer
Number of subjects: 24
Study 14752633 — intervention group
Group type: COMPARATOR
Intervention: No training (control)
Number of subjects: 24
Study 14752633 — intervention group
Group type: EXPERIMENTAL
Intervention: LapSim vs Box trainer
Number of subjects: 24
Study 11523609 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 V amplitude at 0.4 ms pulse duration (for DDD pacemakers)
Number of subjects: 305
Study 11523609 — intervention group
Group type: COMPARATOR
Intervention: 3.5 V amplitude at 0.4 ms pulse duration (for DDD pacemakers)
Number of subjects: 305
Study 11523609 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 V amplitude at 0.4 ms pulse duration (for VVI pacemakers)
Number of subjects: 305
Study 11523609 — intervention group
Group type: COMPARATOR
Intervention: 3.5 V amplitude at 0.4 ms pulse duration (for VVI pacemakers)
Number of subjects: 305
Study 9796839 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 0
Study 7532882 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator (Group S)
Number of subjects: 40
Study 7532882 — intervention group
Group type: COMPARATOR
Intervention: Traditional (Group T)
Number of subjects: 40
Study 3137634 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate infusion
Number of subjects: 0
Study 3137634 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30832554 — intervention group
Group type: EXPERIMENTAL
Intervention: Afatinib
Number of subjects: 123
Study 31578925 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurodynamic sliding technique (3 × 20 reps)
Number of subjects: 50
Study 31578925 — intervention group
Group type: COMPARATOR
Intervention: Static stretching protocol (3 × 30")
Number of subjects: 50
Study 28488230 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warnings proposed by FDA
Number of subjects: 244
Study 28488230 — intervention group
Group type: COMPARATOR
Intervention: Text-only warnings
Number of subjects: 244
Study 28488230 — intervention group
Group type: EXPERIMENTAL
Intervention: Warnings proposed by FDA with additional text
Number of subjects: 244
Study 27704562 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir 1200 mg single oral dose
Number of subjects: 21
Study 27704562 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir 1200 mg co-administered with Efavirenz 600 mg
Number of subjects: 21
Study 24044461 — intervention group
Group type: EXPERIMENTAL
Intervention: Implants placed 3 months after augmentation
Number of subjects: 14
Study 24044461 — intervention group
Group type: COMPARATOR
Intervention: Implants placed 6 months after augmentation
Number of subjects: 14
Study 23082392 — intervention group
Group type: EXPERIMENTAL
Intervention: Test dentifrice (stannous‐containing sodium fluoride with high cleaning silica and polychelation technology)
Number of subjects: 120
Study 23082392 — intervention group
Group type: COMPARATOR
Intervention: Positive control dentifrice (currently marketed whitening dentifrice with ADA Seal of Acceptance)
Number of subjects: 120
Study 23082392 — intervention group
Group type: COMPARATOR
Intervention: Comparison between test dentifrice and positive control dentifrice
Number of subjects: 120
Study 19522571 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 16 mg/kg intravenously every day for 3 days
Number of subjects: 95
Study 19522571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 18546838 — intervention group
Group type: EXPERIMENTAL
Intervention: Epithalamin pineal gland peptide medication
Number of subjects: 0
Study 15793365 — intervention group
Group type: COMPARATOR
Intervention: Genotypic resistance testing alone (G arm)
Number of subjects: 311
Study 15793365 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotypic plus phenotypic testing (G + P arm)
Number of subjects: 311
Study 12418499 — intervention group
Group type: EXPERIMENTAL
Intervention: 1600 mg SAMe/d orally for 6 weeks
Number of subjects: 431
Study 12418499 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg SAMe/d intramuscularly for 4 weeks
Number of subjects: 431
Study 12418499 — intervention group
Group type: COMPARATOR
Intervention: 150 mg imipramine/d orally
Number of subjects: 431
Study 10386277 — intervention group
Group type: EXPERIMENTAL
Intervention: MedEJet
Number of subjects: 75
Study 10386277 — intervention group
Group type: EXPERIMENTAL
Intervention: Biojector
Number of subjects: 75
Study 10386277 — intervention group
Group type: COMPARATOR
Intervention: Needle administration
Number of subjects: 75
Study 8876913 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 0
Study 8876913 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation alone
Number of subjects: 0
Study 8876913 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative irradiation
Number of subjects: 0
Study 8876913 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole abdominal irradiation
Number of subjects: 0
Study 8876913 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation alone in medically inoperable patients
Number of subjects: 0
Study 1882649 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 45
Study 1882649 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal splint
Number of subjects: 45
Study 1882649 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 6641536 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg gentamycin intramuscularly
Number of subjects: 65
Study 6641536 — intervention group
Group type: COMPARATOR
Intervention: 3 g amoxicillin orally
Number of subjects: 65
Study 30928207 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-rTMS (cerebellar low-frequency rTMS, 1200 stimulations per day for 5 days at 90% of resting motor threshold, 1-Hz frequency)
Number of subjects: 22
Study 30928207 — intervention group
Group type: COMPARATOR
Intervention: Sham-rTMS (sham treatment)
Number of subjects: 22
Study 30928207 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-rTMS
Number of subjects: 22
Study 30928207 — intervention group
Group type: COMPARATOR
Intervention: Sham-rTMS
Number of subjects: 22
Study 28697858 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated partial breast irradiation (APBI)
Number of subjects: 79
Study 28697858 — intervention group
Group type: COMPARATOR
Intervention: Whole breast irradiation (WBI)
Number of subjects: 79
Study 28697858 — intervention group
Group type: COMPARATOR
Intervention: No irradiation
Number of subjects: 79
Study 26362661 — intervention group
Group type: EXPERIMENTAL
Intervention: 20g SQ-LNS with 5mg zinc
Number of subjects: 2435
Study 26362661 — intervention group
Group type: EXPERIMENTAL
Intervention: 20g SQ-LNS with 10mg zinc
Number of subjects: 2435
Study 26362661 — intervention group
Group type: EXPERIMENTAL
Intervention: 20g SQ-LNS without zinc and 5mg zinc tablet
Number of subjects: 2435
Study 26362661 — intervention group
Group type: COMPARATOR
Intervention: 20g SQ-LNS without zinc and placebo tablet
Number of subjects: 2435
Study 25271116 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD)
Number of subjects: 61
Study 25271116 — intervention group
Group type: COMPARATOR
Intervention: Low-Fat Diet (LFD)
Number of subjects: 61
Study 22406056 — intervention group
Group type: EXPERIMENTAL
Intervention: CoStar paclitaxel‐eluting stent (PES)
Number of subjects: 238
Study 22406056 — intervention group
Group type: COMPARATOR
Intervention: Taxus paclitaxel‐eluting stent (PES)
Number of subjects: 238
Study 22406056 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple CoStar stenting
Number of subjects: 238
Study 22406056 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Taxus stenting
Number of subjects: 238
Study 22406056 — intervention group
Group type: EXPERIMENTAL
Intervention: Single stenting (both CoStar and Taxus)
Number of subjects: 238
Study 20848367 — intervention group
Group type: EXPERIMENTAL
Intervention: F1 (most flexible)
Number of subjects: 13
Study 20848367 — intervention group
Group type: EXPERIMENTAL
Intervention: F3 (biomimetic ankle-foot roll-over shape)
Number of subjects: 13
Study 20848367 — intervention group
Group type: EXPERIMENTAL
Intervention: F4
Number of subjects: 13
Study 20848367 — intervention group
Group type: EXPERIMENTAL
Intervention: F5 (least flexible)
Number of subjects: 13
Study 20848367 — intervention group
Group type: EXPERIMENTAL
Intervention: F2
Number of subjects: 13
Study 20848367 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen cost (mL O(2)/kg/m)
Number of subjects: 13
Study 20848367 — intervention group
Group type: EXPERIMENTAL
Intervention: Order of use
Number of subjects: 13
Study 17984403 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine hydrochloride (20 mg/d) with CBT
Number of subjects: 126
Study 17984403 — intervention group
Group type: COMPARATOR
Intervention: Placebo with CBT
Number of subjects: 126
Study 15771764 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM (lansoprazole 30 mg b.d., amoxicillin 1 g b.d., metronidazole 400 mg t.d.s.)
Number of subjects: 342
Study 15771764 — intervention group
Group type: EXPERIMENTAL
Intervention: LAC (lansoprazole 30 mg b.d., amoxicillin 1 g b.d., clarithromycin 500 mg b.d.)
Number of subjects: 342
Study 15771764 — intervention group
Group type: EXPERIMENTAL
Intervention: RMT (ranitidine bismuth citrate 400 mg b.d., metronidazole 400 mg t.d.s., tetracycline 500 mg q.d.s.)
Number of subjects: 342
Study 15771764 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM
Number of subjects: 342
Study 15771764 — intervention group
Group type: EXPERIMENTAL
Intervention: LAC
Number of subjects: 342
Study 15771764 — intervention group
Group type: EXPERIMENTAL
Intervention: RMT
Number of subjects: 342
Study 12473020 — intervention group
Group type: EXPERIMENTAL
Intervention: DNR order present
Number of subjects: 241
Study 9617511 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisuride (0.3 mg daily for 12 weeks)
Number of subjects: 22
Study 9617511 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisuride
Number of subjects: 22
Study 9617511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 7650167 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypanosoma cruzi epimastigote ribosomal fraction ELISA
Number of subjects: 216
Study 7650167 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients without Chagas' disease)
Number of subjects: 216
Study 7650167 — intervention group
Group type: EXPERIMENTAL
Intervention: RNP ELISA
Number of subjects: 216
Study 7650167 — intervention group
Group type: EXPERIMENTAL
Intervention: Western blot assay
Number of subjects: 216
Study 7650167 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG isotype distribution
Number of subjects: 216
Study 3297874 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG immunostimulation
Number of subjects: 147
Study 3297874 — intervention group
Group type: COMPARATOR
Intervention: Control (cytostatic drugs and/or surgery without BCG)
Number of subjects: 147
Study 30358728 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral conjugated equine estrogens (0.625 mg/d)
Number of subjects: 10739
Study 30358728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10739
Study 27457964 — intervention group
Group type: EXPERIMENTAL
Intervention: Orteronel 300 mg twice daily
Number of subjects: 47
Study 27457964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 25137428 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg)
Number of subjects: 39
Study 25137428 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole (1 mg)
Number of subjects: 39
Study 22784212 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong exercise program (6 weeks)
Number of subjects: 14
Study 22784212 — intervention group
Group type: COMPARATOR
Intervention: Sham Qigong exercise program (6 weeks)
Number of subjects: 14
Study 20133511 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral treprostinil 1 mg twice daily
Number of subjects: 24
Study 20133511 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan 125 mg twice daily
Number of subjects: 24
Study 20133511 — intervention group
Group type: COMPARATOR
Intervention: Combination of oral treprostinil 1 mg twice daily and bosentan 125 mg twice daily
Number of subjects: 24
Study 18675689 — intervention group
Group type: EXPERIMENTAL
Intervention: H pylori eradication regimen (lansoprazole 30 mg twice daily, amoxicillin 750 mg twice daily, and clarithromycin 200 mg twice daily for a week)
Number of subjects: 544
Study 18675689 — intervention group
Group type: COMPARATOR
Intervention: Standard care (no treatment for H pylori)
Number of subjects: 544
Study 18448418 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg (P150) with ibuprofen 800 mg
Number of subjects: 90
Study 18448418 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg (P75) with ibuprofen 800 mg
Number of subjects: 90
Study 18448418 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 5 mg (D5) with ibuprofen 800 mg
Number of subjects: 90
Study 15034644 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A intake (0.53 mg/day)
Number of subjects: 2016
Study 15034644 — intervention group
Group type: COMPARATOR
Intervention: Highest 5% vitamin A intake
Number of subjects: 2016
Study 15034644 — intervention group
Group type: COMPARATOR
Intervention: Vitamin A intake
Number of subjects: 2016